The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., & Nielsen, L. K. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10655 · Cited by 934
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
Wilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 4×
“However, in conventional 2D cultures, HepG2 cells express low levels of cytochrome P450 (CyP450) enzymes (Wilkening et al. 2003) and the xenobiotic receptors that regulate the expression of drug metabolic enzymes (Kanno and Inouye 2010; naspinski et al.”
BackgroundInfluentialCytochrome P450s and other enzymes in drug metabolism and toxicity
Guengerich, F. P. (2006) · The AAPS Journal · doi:10.1208/aapsj080112 · Cited by 624
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 492
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
Silva, M. F. B., Aires, C. C. P., Luis, P. B. M., Ruiter, J. P. N., IJlst, L., Duran, M., Wanders, R. J. A., & Tavares de Almeida, I. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0841-x · Cited by 382
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
Vavricka, S. R., Van Montfoort, J., Ha, H. R., Meier, P. J., & Fattinger, K. (2002) · Hepatology · doi:10.1053/jhep.2002.34133 · Cited by 373
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Guo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348
Madan, A., Graham, R. A., Carroll, K. M., Mudra, D. R., Burton, L. A., Krueger, L. A., Downey, A. D., Czerwinski, M., Forster, J., Ribadeneira, M. D., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.4.421 · Cited by 338
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects
di Masi, A., Marinis, E. D., Ascenzi, P., & Marino, M. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.002 · Cited by 288
LeCluyse, E. L., Audus, K. L., & Hochman, J. H. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.6.c1764 · Cited by 266
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012) · Hepatology · doi:10.1002/hep.24760 · Cited by 246
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 238
3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies
Gunness, P., Mueller, D., Shevchenko, V., Heinzle, E., Ingelman-Sundberg, M., & Noor, F. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft021 · Cited by 236
Undifferentiated Tumor: True Identity by Immunohistochemistry
Bahrami, A., Truong, L. D., & Ro, J. Y. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2008-132-326-uttibi · Cited by 208
Use of Micropatterned Cocultures to Detect Compounds That Cause Drug-Induced Liver Injury in Humans
Khetani, S. R., Kanchagar, C., Ukairo, O., Krzyzewski, S., Moore, A., Shi, J., Aoyama, S., Aleo, M., & Will, Y. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs326 · Cited by 208
Fey, S. J., & Wrzesinski, K. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs122 · Cited by 188
Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7])
Kobayashi, Y., Ohshiro, N., Sakai, R., Ohbayashi, M., Kohyama, N., & Yamamoto, T. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055966 · Cited by 178
Kiang, T. K. L., Ho, P. C., Anari, M. R., Tong, V., Abbott, F. S., & Chang, T. K. H. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl096 · Cited by 160
3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies
Mueller, D., Krämer, L., Hoffmann, E., Klein, S., & Noor, F. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.06.024 · Cited by 159
Hoffmaster, K. A., Turncliff, R. Z., LeCluyse, E. L., Kim, R. B., Meier, P. J., & Brouwer, K. L. R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033018.97745.0d · Cited by 156
Organic anion transporter (Slc22a) family members as mediators of toxicity
Sweet, D. H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.016 · Cited by 150 · cited 1×
“The expression levels of OAT2 and OAT7, which represent major transporters of various clinically relevant drug classes (Kobayashi et al. 2005; sweet 2005), were highly increased in spheroids compared to 2D culture.”
Backgroundvan de Steeg, E., van Esch, A., Wagenaar, E., Kenworthy, K. E., & Schinkel, A. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2080 · Cited by 145
Toxicity Testing in the 21st Century: A View from the Pharmaceutical Industry
MacDonald, J. S., & Robertson, R. T. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp088 · Cited by 115
The maintenance and generation of membrane polarity in hepatocytes
Wang, L., & Boyer, J. L. (2004) · Hepatology · doi:10.1002/hep.20039 · Cited by 113
Microtissue size and hypoxia in HTS with 3D cultures
Asthana, A., & Kisaalita, W. S. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.004 · Cited by 104
Fredriksson, L., Herpers, B., Benedetti, G., Matadin, Q., Puigvert, J. C., de Bont, H., Dragović, S., Vermeulen, N. P. E., Commandeur, J. N. M., Danen, E. H. J., et al. (2011) · Hepatology · doi:10.1002/hep.24314 · Cited by 102
Self-citationHepatic Transport Mechanisms of Cholyl-l-Lysyl-Fluorescein
de Waart, D. R., Häusler, S., Vlaming, M. L. H., Kunne, C., Hänggi, E., Gruss, H.-J., Elferink, R. P. J. O., & Stieger, B. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166991 · Cited by 92
Abe, K., Bridges, A. S., & Brouwer, K. L. R. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023465 · Cited by 77
Choi, M. H., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003327 · Cited by 74
Pregnane X Receptor Protects HepG2 Cells from BaP-Induced DNA Damage
Naspinski, C., Gu, X., Zhou, G.-D., Mertens‐Talcott, S. U., Donnelly, K. C., & Tian, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn058 · Cited by 73
Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system
Nakamura, K., Mizutani, R., Sanbe, A., Enosawa, S., Kasahara, M., Nakagawa, A., Ejiri, Y., Murayama, N., Miyamoto, Y., Torii, T., et al. (2010) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2010.08.008 · Cited by 63
Küblbeck, J., Jyrkkärinne, J., Molnár, F., Kuningas, T., Patel, J. Z., Windshügel, B., Nevalainen, T., Laitinen, T., Sippl, W., Poso, A., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2003658 · Cited by 50
Beggs, K. M., Fullerton, A. M., Miyakawa, K., Ganey, P. E., & Roth, R. A. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft226 · Cited by 37
Kanno, Y., & Inouye, Y. (2010) · The Journal of Toxicological Sciences · doi:10.2131/jts.35.515 · Cited by 36
Three-dimensional polarization sensitizes hepatocytes to Fas/CD95 apoptotic signalling
Haouzi, D., Baghdiguian, S., Granier, G., Travo, P., Mangeat, P. H., & Hibner, U. (2005) · Journal of Cell Science · doi:10.1242/jcs.02403 · Cited by 35
Malinen, M. M., Palokangas, H., Yliperttula, M. L., & Urtti, A. O. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0046 · Cited by 33
Improved Hepatocyte Excretory Function by Immediate Presentation of Polarity Cues
Ng, S., Han, R., Chang, S., Ni, J., Hunziker, W., Goryachev, A. B., Ong, S. H., & Yu, H. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.2181 · Cited by 33
Matsui, H., Takeuchi, S., Osada, T., Fujii, T., & Sakai, Y. (2012) · Lab on a Chip · doi:10.1039/c2lc40046d · Cited by 28
Pharmacokinetics and metabolism of single oral doses of trovafloxacin
Vincent, J., Teng, R., Dalvie, D., & Friedman, H. L. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00213-x · Cited by 26
QSG‐7701 human hepatocytes form polarized acini in three‐dimensional culture
Zhang, F., Xu, R., & Zhao, M. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22632 · Cited by 16
Chen, G., Li, S., Dong, X., Bai, Y., Chen, A., Yang, S., Fang, M., Zamaratskaia, G., & Doran, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052255 · Cited by 12
Cited by
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
“Liver OOCs contain hepatocytes and fibroblasts arranged in meaningful ways by patterning (Khetani and Bhatia, 2008; Cho et al., 2010) or cultured in aggregates (Ramaiahgari et al., 2014; Bhise et al., 2016).”
BackgroundMicrofluidic 3D cell culture: from tools to tissue models
van Duinen, V., Trietsch, S. J., Joore, J., Vulto, P., & Hankemeier, T. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.002 · Cited by 500
Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling
Chaicharoenaudomrung, N., Kunhorm, P., & Noisa, P. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i12.1065 · Cited by 360
Ning, C., Wang, X., Li, L., Zhu, Y., Li, M., Yu, P., Zhou, L., Zhou, Z., Chen, J., Tan, G., et al. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00258 · Cited by 344
Breslin, S., & O’Driscoll, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9935 · Cited by 311
Metadata
- Authors
- Ramaiahgari, S. C., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., & Price, L. S.
- Venue
- Archives of Toxicology
- Published
- 2014-03-06
- Volume
- 88
- Issue
- 5
- Pages
- 1083-95
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2109850567
- Cited by
- 364
- References
- 47
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.